Global Insomnia Therapy Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Market Analysis by Type
1.3.1 Global Insomnia Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.3.2 Non-pharmacological Therapy
1.3.3 Pharmacological Therapy
1.4 Market by Application
1.4.1 Global Insomnia Therapy Market Share by Application: 2020 VS 2026
1.4.2 Hospital
1.4.3 Ambulatory Surgical Center
1.4.4 Home Care
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Insomnia Therapy Market Perspective (2015-2026)
2.2 Insomnia Therapy Growth Trends by Regions
2.2.1 Insomnia Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Insomnia Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Insomnia Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Insomnia Therapy Industry Dynamic
2.3.1 Insomnia Therapy Market Trends
2.3.2 Insomnia Therapy Market Drivers
2.3.3 Insomnia Therapy Market Challenges
2.3.4 Insomnia Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Insomnia Therapy Players by Market Size
3.1.1 Global Top Insomnia Therapy Players by Revenue (2015-2020)
3.1.2 Global Insomnia Therapy Revenue Market Share by Players (2015-2020)
3.2 Global Insomnia Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Insomnia Therapy Revenue
3.4 Global Insomnia Therapy Market Concentration Ratio
3.4.1 Global Insomnia Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Insomnia Therapy Revenue in 2019
3.5 Key Players Insomnia Therapy Area Served
3.6 Key Players Insomnia Therapy Product Solution and Service
3.7 Date of Enter into Insomnia Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Insomnia Therapy Breakdown Data by Type
4.1 Global Insomnia Therapy Historic Market Size by Type (2015-2020)
4.2 Global Insomnia Therapy Forecasted Market Size by Type (2021-2026)
5 Insomnia Therapy Breakdown Data by Application
5.1 Global Insomnia Therapy Historic Market Size by Application (2015-2020)
5.2 Global Insomnia Therapy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Insomnia Therapy Market Size (2015-2026)
6.2 North America Insomnia Therapy Market Size by Type (2015-2020)
6.3 North America Insomnia Therapy Market Size by Application (2015-2020)
6.4 North America Insomnia Therapy Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Insomnia Therapy Market Size (2015-2026)
7.2 Europe Insomnia Therapy Market Size by Type (2015-2020)
7.3 Europe Insomnia Therapy Market Size by Application (2015-2020)
7.4 Europe Insomnia Therapy Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Insomnia Therapy Market Size (2015-2026)
8.2 Asia-Pacific Insomnia Therapy Market Size by Type (2015-2020)
8.3 Asia-Pacific Insomnia Therapy Market Size by Application (2015-2020)
8.4 Asia-Pacific Insomnia Therapy Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
9 Latin America
9.1 Latin America Insomnia Therapy Market Size (2015-2026)
9.2 Latin America Insomnia Therapy Market Size by Type (2015-2020)
9.3 Latin America Insomnia Therapy Market Size by Application (2015-2020)
9.4 Latin America Insomnia Therapy Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Insomnia Therapy Market Size (2015-2026)
10.2 Middle East & Africa Insomnia Therapy Market Size by Type (2015-2020)
10.3 Middle East & Africa Insomnia Therapy Market Size by Application (2015-2020)
10.4 Middle East & Africa Insomnia Therapy Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11Key Players Profiles
11.1 Merck & Co.
11.1.1 Merck & Co. Company Details
11.1.2 Merck & Co. Business Overview
11.1.3 Merck & Co. Insomnia Therapy Introduction
11.1.4 Merck & Co. Revenue in Insomnia Therapy Business (2015-2020))
11.1.5 Merck & Co. Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Insomnia Therapy Introduction
11.2.4 Sanofi Revenue in Insomnia Therapy Business (2015-2020)
11.2.5 Sanofi Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Insomnia Therapy Introduction
11.3.4 Pfizer Revenue in Insomnia Therapy Business (2015-2020)
11.3.5 Pfizer Recent Development
11.4 Takeda Pharmaceutical Company Ltd.
11.4.1 Takeda Pharmaceutical Company Ltd. Company Details
11.4.2 Takeda Pharmaceutical Company Ltd. Business Overview
11.4.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Introduction
11.4.4 Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapy Business (2015-2020)
11.4.5 Takeda Pharmaceutical Company Ltd. Recent Development
11.5 Purdue Pharmaceuticals L.P.
11.5.1 Purdue Pharmaceuticals L.P. Company Details
11.5.2 Purdue Pharmaceuticals L.P. Business Overview
11.5.3 Purdue Pharmaceuticals L.P. Insomnia Therapy Introduction
11.5.4 Purdue Pharmaceuticals L.P. Revenue in Insomnia Therapy Business (2015-2020)
11.5.5 Purdue Pharmaceuticals L.P. Recent Development
11.6 Eisai, Co. Ltd.
11.6.1 Eisai, Co. Ltd. Company Details
11.6.2 Eisai, Co. Ltd. Business Overview
11.6.3 Eisai, Co. Ltd. Insomnia Therapy Introduction
11.6.4 Eisai, Co. Ltd. Revenue in Insomnia Therapy Business (2015-2020)
11.6.5 Eisai, Co. Ltd. Recent Development
11.7 Meda Consumer Healthcare
11.7.1 Meda Consumer Healthcare Company Details
11.7.2 Meda Consumer Healthcare Business Overview
11.7.3 Meda Consumer Healthcare Insomnia Therapy Introduction
11.7.4 Meda Consumer Healthcare Revenue in Insomnia Therapy Business (2015-2020)
11.7.5 Meda Consumer Healthcare Recent Development
11.8 Pernix Therapeutics
11.8.1 Pernix Therapeutics Company Details
11.8.2 Pernix Therapeutics Business Overview
11.8.3 Pernix Therapeutics Insomnia Therapy Introduction
11.8.4 Pernix Therapeutics Revenue in Insomnia Therapy Business (2015-2020)
11.8.5 Pernix Therapeutics Recent Development
11.9 Vanda Pharmaceuticals
11.9.1 Vanda Pharmaceuticals Company Details
11.9.2 Vanda Pharmaceuticals Business Overview
11.9.3 Vanda Pharmaceuticals Insomnia Therapy Introduction
11.9.4 Vanda Pharmaceuticals Revenue in Insomnia Therapy Business (2015-2020)
11.9.5 Vanda Pharmaceuticals Recent Development
11.10 ECR Pharmaceuticals
11.10.1 ECR Pharmaceuticals Company Details
11.10.2 ECR Pharmaceuticals Business Overview
11.10.3 ECR Pharmaceuticals Insomnia Therapy Introduction
11.10.4 ECR Pharmaceuticals Revenue in Insomnia Therapy Business (2015-2020)
11.10.5 ECR Pharmaceuticals Recent Development
11.11 Fidia Farmaceutici
10.11.1 Fidia Farmaceutici Company Details
10.11.2 Fidia Farmaceutici Business Overview
10.11.3 Fidia Farmaceutici Insomnia Therapy Introduction
10.11.4 Fidia Farmaceutici Revenue in Insomnia Therapy Business (2015-2020)
10.11.5 Fidia Farmaceutici Recent Development
11.12 Dainippon Sumitomo
10.12.1 Dainippon Sumitomo Company Details
10.12.2 Dainippon Sumitomo Business Overview
10.12.3 Dainippon Sumitomo Insomnia Therapy Introduction
10.12.4 Dainippon Sumitomo Revenue in Insomnia Therapy Business (2015-2020)
10.12.5 Dainippon Sumitomo Recent Development
11.13 Biocodex
10.13.1 Biocodex Company Details
10.13.2 Biocodex Business Overview
10.13.3 Biocodex Insomnia Therapy Introduction
10.13.4 Biocodex Revenue in Insomnia Therapy Business (2015-2020)
10.13.5 Biocodex Recent Development
11.14 Eli Lilly and Company
10.14.1 Eli Lilly and Company Company Details
10.14.2 Eli Lilly and Company Business Overview
10.14.3 Eli Lilly and Company Insomnia Therapy Introduction
10.14.4 Eli Lilly and Company Revenue in Insomnia Therapy Business (2015-2020)
10.14.5 Eli Lilly and Company Recent Development
11.15 Ebb Therapeutics
10.15.1 Ebb Therapeutics Company Details
10.15.2 Ebb Therapeutics Business Overview
10.15.3 Ebb Therapeutics Insomnia Therapy Introduction
10.15.4 Ebb Therapeutics Revenue in Insomnia Therapy Business (2015-2020)
10.15.5 Ebb Therapeutics Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Insomnia Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 2. Key Players of Non-pharmacological Therapy
Table 3. Key Players of Pharmacological Therapy
Table 4. Global Insomnia Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 5. Global Insomnia Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 6. Global Insomnia Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 7. Global Insomnia Therapy Market Share by Regions (2015-2020)
Table 8. Global Insomnia Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 9. Global Insomnia Therapy Market Share by Regions (2021-2026)
Table 10. Insomnia Therapy Market Market Trends
Table 11. Insomnia Therapy Market Drivers
Table 12. Insomnia Therapy Market Challenges
Table 13. Insomnia Therapy Market Restraints
Table 14. Global Insomnia Therapy Revenue by Players (2015-2020) (US$ Million)
Table 15. Global Insomnia Therapy Market Share by Players (2015-2020)
Table 16. Global Top Insomnia Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insomnia Therapy as of 2019)
Table 17. Global Insomnia Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 18. Key Players Headquarters and Area Served
Table 19. Key Players Insomnia Therapy Product Solution and Service
Table 20. Mergers & Acquisitions, Expansion Plans
Table 21. Global Insomnia Therapy Market Size by Type (2015-2020) (US$ Million)
Table 22. Global Insomnia Therapy Revenue Market Share by Type (2015-2020)
Table 23. Global Insomnia Therapy Forecasted Market Size by Type (2021-2026) (US$ Million)
Table 24. Global Insomnia Therapy Market Size Share by Application (2015-2020) (US$ Million)
Table 25. Global Insomnia Therapy Revenue Market Share by Application (2015-2020)
Table 26. Global Insomnia Therapy Forecasted Market Size by Application (2021-2026) (US$ Million)
Table 27. North America Insomnia Therapy Market Size by Type (2015-2020) (US$ Million)
Table 28. North America Insomnia Therapy Market Share by Type (2015-2020)
Table 29. North America Insomnia Therapy Market Size by Application (2015-2020) (US$ Million)
Table 30. North America Insomnia Therapy Market Share by Application (2015-2020)
Table 31. North America Insomnia Therapy Market Size by Country (US$ Million) (2015-2020)
Table 32. North America Insomnia Therapy Market Share by Country (2015-2020)
Table 33. Europe Insomnia Therapy Market Size by Type (2015-2020) (US$ Million)
Table 34. Europe Insomnia Therapy Market Share by Type (2015-2020)
Table 35. Europe Insomnia Therapy Market Size by Application (2015-2020) (US$ Million)
Table 36. Europe Insomnia Therapy Market Share by Application (2015-2020)
Table 37. Europe Insomnia Therapy Market Size by Country (US$ Million) (2015-2020)
Table 38. Europe Insomnia Therapy Market Share by Country (2015-2020)
Table 39. Asia-Pacific Insomnia Therapy Market Size by Type (2015-2020) (US$ Million)
Table 40. Asia-Pacific Insomnia Therapy Market Share by Type (2015-2020)
Table 41. Asia-Pacific Insomnia Therapy Market Size by Application (2015-2020) (US$ Million)
Table 42. Asia-Pacific Insomnia Therapy Market Share by Application (2015-2020)
Table 43. Asia-Pacific Insomnia Therapy Market Size by Region (US$ Million) (2015-2020)
Table 44. Asia-Pacific Insomnia Therapy Market Share by Region (2015-2020)
Table 45. Latin America Insomnia Therapy Market Size by Type (2015-2020) (US$ Million)
Table 46. Latin America Insomnia Therapy Market Share by Type (2015-2020)
Table 47. Latin America Insomnia Therapy Market Size by Application (2015-2020) (US$ Million)
Table 48. Latin America Insomnia Therapy Market Share by Application (2015-2020)
Table 49. Latin America Insomnia Therapy Market Size by Country (US$ Million) (2015-2020)
Table 50. Latin America Insomnia Therapy Market Share by Country (2015-2020)
Table 51. Middle East & Africa Insomnia Therapy Market Size by Type (2015-2020) (US$ Million)
Table 52. Middle East & Africa Insomnia Therapy Market Share by Type (2015-2020)
Table 53. Middle East & Africa Insomnia Therapy Market Size by Application (2015-2020) (US$ Million)
Table 54. Middle East & Africa Insomnia Therapy Market Share by Application (2015-2020)
Table 55. Middle East & Africa Insomnia Therapy Market Size by Country (US$ Million) (2015-2020)
Table 56. Middle East & Africa Insomnia Therapy Market Share by Country (2015-2020)
Table 57. Merck & Co. Company Details
Table 58. Merck & Co. Business Overview
Table 59. Merck & Co. Insomnia Therapy Product
Table 60. Merck & Co. Revenue in Insomnia Therapy Business (2015-2020) (US$ Million)
Table 61. Merck & Co. Recent Development
Table 62. Sanofi Company Details
Table 63. Sanofi Business Overview
Table 64. Sanofi Insomnia Therapy Product
Table 65. Sanofi Revenue in Insomnia Therapy Business (2015-2020) (US$ Million)
Table 66. Sanofi Recent Development
Table 67. Pfizer Company Details
Table 68. Pfizer Business Overview
Table 69. Pfizer Insomnia Therapy Product
Table 70. Pfizer Revenue in Insomnia Therapy Business (2015-2020) (US$ Million)
Table 71. Pfizer Recent Development
Table 72. Takeda Pharmaceutical Company Ltd. Company Details
Table 73. Takeda Pharmaceutical Company Ltd. Business Overview
Table 74. Takeda Pharmaceutical Company Ltd. Insomnia Therapy Product
Table 75. Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapy Business (2015-2020) (US$ Million)
Table 76. Takeda Pharmaceutical Company Ltd. Recent Development
Table 77. Purdue Pharmaceuticals L.P. Company Details
Table 78. Purdue Pharmaceuticals L.P. Business Overview
Table 79. Purdue Pharmaceuticals L.P. Insomnia Therapy Product
Table 80. Purdue Pharmaceuticals L.P. Revenue in Insomnia Therapy Business (2015-2020) (US$ Million)
Table 81. Purdue Pharmaceuticals L.P. Recent Development
Table 82. Eisai, Co. Ltd. Company Details
Table 83. Eisai, Co. Ltd. Business Overview
Table 84. Eisai, Co. Ltd. Insomnia Therapy Product
Table 85. Eisai, Co. Ltd. Revenue in Insomnia Therapy Business (2015-2020) (US$ Million)
Table 86. Eisai, Co. Ltd. Recent Development
Table 87. Meda Consumer Healthcare Company Details
Table 88. Meda Consumer Healthcare Business Overview
Table 89. Meda Consumer Healthcare Insomnia Therapy Product
Table 90. Meda Consumer Healthcare Revenue in Insomnia Therapy Business (2015-2020) (US$ Million)
Table 91. Meda Consumer Healthcare Recent Development
Table 92. Pernix Therapeutics Business Overview
Table 93. Pernix Therapeutics Insomnia Therapy Product
Table 94. Pernix Therapeutics Company Details
Table 95. Pernix Therapeutics Revenue in Insomnia Therapy Business (2015-2020) (US$ Million)
Table 96. Pernix Therapeutics Recent Development
Table 97. Vanda Pharmaceuticals Company Details
Table 98. Vanda Pharmaceuticals Business Overview
Table 99. Vanda Pharmaceuticals Insomnia Therapy Product
Table 100. Vanda Pharmaceuticals Revenue in Insomnia Therapy Business (2015-2020) (US$ Million)
Table 101. Vanda Pharmaceuticals Recent Development
Table 102. ECR Pharmaceuticals Company Details
Table 103. ECR Pharmaceuticals Business Overview
Table 104. ECR Pharmaceuticals Insomnia Therapy Product
Table 105. ECR Pharmaceuticals Revenue in Insomnia Therapy Business (2015-2020) (US$ Million)
Table 106. ECR Pharmaceuticals Recent Development
Table 107. Fidia Farmaceutici Company Details
Table 108. Fidia Farmaceutici Business Overview
Table 109. Fidia Farmaceutici Insomnia Therapy Product
Table 110. Fidia Farmaceutici Revenue in Insomnia Therapy Business (2015-2020) (US$ Million)
Table 111. Fidia Farmaceutici Recent Development
Table 112. Dainippon Sumitomo Company Details
Table 113. Dainippon Sumitomo Business Overview
Table 114. Dainippon Sumitomo Insomnia Therapy Product
Table 115. Dainippon Sumitomo Revenue in Insomnia Therapy Business (2015-2020) (US$ Million)
Table 116. Dainippon Sumitomo Recent Development
Table 117. Biocodex Company Details
Table 118. Biocodex Business Overview
Table 119. Biocodex Insomnia Therapy Product
Table 120. Biocodex Revenue in Insomnia Therapy Business (2015-2020) (US$ Million)
Table 121. Biocodex Recent Development
Table 122. Eli Lilly and Company Company Details
Table 123. Eli Lilly and Company Business Overview
Table 124. Eli Lilly and Company Insomnia Therapy Product
Table 125. Eli Lilly and Company Revenue in Insomnia Therapy Business (2015-2020) (US$ Million)
Table 126. Eli Lilly and Company Recent Development
Table 127. Ebb Therapeutics Company Details
Table 128. Ebb Therapeutics Business Overview
Table 129. Ebb Therapeutics Insomnia Therapy Product
Table 130. Ebb Therapeutics Revenue in Insomnia Therapy Business (2015-2020) (US$ Million)
Table 131. Ebb Therapeutics Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Insomnia Therapy Market Share by Type: 2020 VS 2026
Figure 2. Non-pharmacological Therapy Features
Figure 3. Pharmacological Therapy Features
Figure 4. Global Insomnia Therapy Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Ambulatory Surgical Center Case Studies
Figure 7. Home Care Case Studies
Figure 8. Insomnia Therapy Report Years Considered
Figure 9. Global Insomnia Therapy Market Size (US$ Million), YoY Growth 2015-2026
Figure 10. Global Insomnia Therapy Market Share by Regions: 2020 VS 2026
Figure 11. Global Insomnia Therapy Market Share by Regions (2021-2026)
Figure 12. Global Insomnia Therapy Market Share by Players in 2019
Figure 13. Global Top Insomnia Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insomnia Therapy as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Insomnia Therapy Revenue in 2019
Figure 15. North America Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 16. United States Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. Canada Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Europe Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Germany Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. France Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. U.K. Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Italy Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Russia Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Nordic Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Asia-Pacific Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. China Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Japan Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. South Korea Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Southeast Asia Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. India Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Australia Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Rest of Asia-Pacific Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Latin America Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Mexico Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Brazil Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Middle East & Africa Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Turkey Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Saudi Arabia Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. UAE Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Merck & Co. Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 41. Sanofi Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 42. Pfizer Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 43. Takeda Pharmaceutical Company Ltd. Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 44. Purdue Pharmaceuticals L.P. Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 45. Eisai, Co. Ltd. Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 46. Meda Consumer Healthcare Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 47. Pernix Therapeutics Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 48. Vanda Pharmaceuticals Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 49. ECR Pharmaceuticals Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 50. Fidia Farmaceutici Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 51. Dainippon Sumitomo Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 52. Biocodex Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 53. Eli Lilly and Company Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 54. Ebb Therapeutics Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed